For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

Infusions of platelet factor 4 (PF4) have reversed aging in human hematopoietic stem cells (HSCs), the precursors of a range of blood and immune cells. A team from the University of Illinois Chicago ...

In recent years, there has been a growing trend of an aging patient population and an increasing prevalence of age-associated diseases, underscoring the need for advancing research into the biological ...

It has only recently become known that two parallel systems of blood formation exist in the body, originating from different precursor cells. Researchers at the German Cancer Research Center (DKFZ) ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Stem Cell Therapy for Cancer Treatment - As life expectancies increase and lifestyle diseases become more common, preserving stem cells offers valuable insurance against future health challenges.